Australia's Botanix Pharmaceuticals gains on agreement with UpScriptHealth
24/10/2023 05:51
** Shares of Botanix Pharmaceuticals BOT.AX rise as much
as 4% to A$0.13
** Dermatology co says it has signed an exclusive agreement
with digital prescription co UpScriptHealth
** Says agreement to provide digital platform and telehealth
services for the commercial launch of Sofdra gel
** Stock has more than doubled this year, since last close
(Reporting by Ayushman Ojha in Bengaluru)
((Ayushman.ojha@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million